{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T20:17:37Z","timestamp":1790972257212,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1016\/j.jneuroim.2011.05.006","type":"journal-article","created":{"date-parts":[[2011,6,19]],"date-time":"2011-06-19T10:20:40Z","timestamp":1308478840000},"page":"39-46","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson disease"],"prefix":"10.1016","volume":"236","author":[{"given":"Candan","family":"Depboylu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Schorlemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Klietz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wolfgang H.","family":"Oertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eberhard","family":"Weihe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00fcnter U.","family":"H\u00f6glinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin K.-H.","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2011.05.006_bb0005","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/glia.20015","article-title":"Evidence of active microglia in substantia nigra pars compacta of parkinsonian monkeys 1year after MPTP exposure","volume":"46","author":"Barcia","year":"2004","journal-title":"Glia"},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/ana.21524","article-title":"Immunoglobulins and complement in postmortem multiple sclerosis tissue","volume":"65","author":"Barnett","year":"2009","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0015","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0022-510X(73)90175-5","article-title":"Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations","volume":"20","author":"Bernheimer","year":"1973","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0020","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/1098-2396(20001201)38:3<363::AID-SYN16>3.0.CO;2-A","article-title":"Spontaneous long-term compensatory dopaminergic sprouting in MPTP-treated mice","volume":"38","author":"Bezard","year":"2000","journal-title":"Synapse"},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0025","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/ng0598-56","article-title":"Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies","volume":"19","author":"Botto","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0030","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.nbd.2005.01.030","article-title":"Increase of C1q biosynthesis in brain microglia and macrophages during lentivirus infection in the rhesus macaque is sensitive to antiretroviral treatment with 6-chloro-2\u2032,3\u2032-dideoxyguanosine","volume":"20","author":"Depboylu","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0035","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/NEN.0b013e31820805b9","article-title":"Possible involvement of complement factor C1q in the clearance of extracellular neuromelanin from the substantia nigra in Parkinson disease","volume":"70","author":"Depboylu","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0022-510X(94)00269-T","article-title":"Expression of C1q, a subcomponent of the rat complement system, is dramatically enhanced in brains of rats with either Borna disease or experimental allergic encephalomyelitis","volume":"130","author":"Dietzschold","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0045","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/jnr.21875","article-title":"C1q, the recognition subcomponent of the classical pathway of complement, drives microglial activation","volume":"87","author":"F\u00e4rber","year":"2009","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0050","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.4049\/jimmunol.170.11.5764","article-title":"Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease","volume":"170","author":"Farkas","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0055","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.molimm.2004.06.011","article-title":"Complement: a unique innate immune sensor for danger signals","volume":"41","author":"Gasque","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0060","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0162-3109(00)80302-1","article-title":"Complement components of the innate immune system in health and disease in the CNS","volume":"49","author":"Gasque","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0065","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1126\/science.6610213","article-title":"Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine in mice","volume":"224","author":"Heikkila","year":"1984","journal-title":"Science"},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0070","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/334345a0","article-title":"Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease","volume":"334","author":"Hirsch","year":"1988","journal-title":"Nature"},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0075","doi-asserted-by":"crossref","first-page":"3585","DOI":"10.1073\/pnas.0611671104","article-title":"The pRb\/E2F cell-cycle pathway mediates cell death in Parkinson's disease","volume":"104","author":"H\u00f6glinger","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0080","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nm1419","article-title":"Generation of C5a in the absence of C3: a new complement activation pathway","volume":"12","author":"Huber-Lang","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0085","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00401-003-0766-2","article-title":"Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains","volume":"106","author":"Imamura","year":"2003","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0095","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/1055-8330(95)90015-2","article-title":"Time course and morphology of dopaminergic neuronal death caused by the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"4","author":"Jackson-Lewis","year":"1995","journal-title":"Neurodegeneration"},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0100","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/86567","article-title":"Complement facilitates early prion pathogenesis","volume":"7","author":"Klein","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0105","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.nbd.2005.01.023","article-title":"Bone marrow-derived microglia contribute to the neuroinflammatory response and express iNOS in the MPTP mouse model of Parkinson's disease","volume":"19","author":"Kokovay","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0110","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.nbd.2003.09.010","article-title":"Complement activation in human prion disease","volume":"15","author":"Kovacs","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0115","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1006\/exnr.1998.6993","article-title":"The inflammatory reaction following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine intoxication in mouse","volume":"156","author":"Kurkowska-Jastrzebska","year":"1999","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0120","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/1531-8249(199910)46:4<598::AID-ANA7>3.0.CO;2-F","article-title":"Evidence of active nerve cell degeneration in the substantia nigra of humans years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine exposure","volume":"46","author":"Langston","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0125","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.brainres.2007.08.033","article-title":"Complement 3-deficient mice are not protected against MPTP-induced dopaminergic neurotoxicity","volume":"1178","author":"Liang","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0130","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0135","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1742-2094-3-29","article-title":"Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study","volume":"3","author":"Loeffler","year":"2006","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0140","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.molimm.2003.08.009","article-title":"Microglial activation and increased synthesis of complement component C1q precedes blood\u2013brain barrier dysfunction in rats","volume":"40","author":"Lynch","year":"2004","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0145","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0150","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/ana.10728","article-title":"Presence of reactive microglia in monkey substantia nigra years after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine administration","volume":"54","author":"McGeer","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0155","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1084\/jem.188.12.2313","article-title":"Complement-dependent clearance of apoptotic cells by human macrophages","volume":"188","author":"Mevorach","year":"1998","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0160","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1006\/bbrc.1998.8986","article-title":"Spontaneous regeneration of nigrostriatal dopaminergic neurons in MPTP-treated C57BL\/6 mice","volume":"248","author":"Mitsumoto","year":"1998","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0165","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.neuroscience.2006.02.007","article-title":"Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine\/probenecid model of Parkinson's disease","volume":"140","author":"Novikova","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0170","doi-asserted-by":"crossref","first-page":"3988","DOI":"10.4049\/jimmunol.147.11.3988","article-title":"Gene expression of the A- and B-chain of mouse C1q in different tissues and the characterization of the recombinant A-chain","volume":"147","author":"Petry","year":"1991","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0175","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1038\/nm1201-1356","article-title":"Targeting gene-modified hematopoietic cells to the central nervous system: use of green fluorescent protein uncovers microglial engraftment","volume":"7","author":"Priller","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0180","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1046\/j.1471-4159.2001.00183.x","article-title":"The parkinsonian toxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a technical review of its utility and safety","volume":"76","author":"Przedborski","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0185","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.nbd.2007.07.024","article-title":"Bone-marrow-derived cell differentiation into microglia: a study in a progressive mouse model of Parkinson's disease","volume":"28","author":"Rodriguez","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0190","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s004010000225","article-title":"Activated microglial cells and complement factors are unrelated to cortical Lewy bodies","volume":"100","author":"Rozemuller","year":"2000","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0195","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.4049\/jimmunol.164.10.5446","article-title":"Complement C1q is dramatically up-regulated in brain microglia in response to transient global cerebral ischemia","volume":"164","author":"Sch\u00e4fer","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0200","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.4049\/jimmunol.155.10.4971","article-title":"Follicular dendritic cells, interdigitating cells, and cells of the monocyte\u2013macrophage lineage are the C1q-producing sources in the spleen. Identification of specific cell types by in situ hybridization and immunohistochemical analysis","volume":"155","author":"Schwaeble","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0205","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1042\/bj2740481","article-title":"Characterization and organization of the genes encoding the A-, B- and C-chains of human complement subcomponent C1q. The complete derived amino acid sequence of human C1q","volume":"274","author":"Sellar","year":"1991","journal-title":"Biochem. J."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0210","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1096\/fj.04-1517fje","article-title":"Bone marrow stem cells have the ability to populate the entire central nervous system into fully differentiated parenchymal microglia","volume":"18","author":"Simard","year":"2004","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0215","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/j.cell.2007.10.036","article-title":"The classical complement cascade mediates CNS synapse elimination","volume":"131","author":"Stevens","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0220","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining","volume":"77","author":"Tatton","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0225","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1096\/fj.05-5814com","article-title":"Therapeutic activity of C5a receptor antagonists in a rat model of neurodegeneration","volume":"20","author":"Woodruff","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0230","doi-asserted-by":"crossref","first-page":"10837","DOI":"10.1073\/pnas.162350199","article-title":"Prominent neurodegeneration and increased plaque formation in complement-inhibited Alzheimer's mice","volume":"99","author":"Wyss-Coray","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jneuroim.2011.05.006_bb0235","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00427222","article-title":"Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins","volume":"84","author":"Yamada","year":"1992","journal-title":"Acta Neuropathol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572811001354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572811001354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:16:48Z","timestamp":1759047408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572811001354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":47,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S0165572811001354"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2011.05.006","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Upregulation of microglial C1q expression has no effects on nigrostriatal dopaminergic injury in the MPTP mouse model of Parkinson disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2011.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}